591
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: A cost-effectiveness analysis in Greece

, &
Pages 678-684 | Accepted 22 Feb 2013, Published online: 13 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Articles from other publishers (5)

Changcheng Shi, Jian Ye, Yaping Xie, Rong Dong, Weizhong Jin, Linling Wang, Yingying Fang, Qiyuan Shan & Nengming Lin. (2022) Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China. Frontiers in Public Health 10.
Crossref
Pinki Mishra, Narendra Agrawal, Dinesh Bhurani & Nidhi Bharal Agarwal. (2019) Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy. Indian Journal of Hematology and Blood Transfusion 36:1, pages 64-70.
Crossref
Hyeon Jeong Suh, Inho Kim, Joo-Youn ChoSang-In ParkSeo Hyun YoonJoo-Hee Hwang, Ji Yun Bae, Jeong-Ok Lee, Youngil Koh, Kyoung-Ho Song, Pyoeng Gyun Choe, Kyung-Sang YuEu Suk Kim, Hong Bin Kim, Soo-Mee Bang, Nam Joong Kim, Sang Hoon SongWan Beom Park & Myoung-don Oh. (2018) Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies. Therapeutic Drug Monitoring 40:1, pages 115-119.
Crossref
Rafael Cámara, Irmina Gozalbo, Manuel Jurado, Jaime Sanz, Belén Aragón & Santiago Grau. (2017) Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain. Advances in Therapy 34:9, pages 2104-2119.
Crossref
Wei YuanJinhai RenXiaonan GuoXiaoling GuoShengxin Cai. (2016) Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China. Medical Science Monitor 22, pages 4226-4232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.